People with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood have a lower risk of dementia, including a lower risk of dementia related to Alzheimer’s disease, shows a study published online in The Journal of Neurology Neurosurgery and Psychiatry . Statin use provided an additional protective effect for people with low LDL-C, specifically those with
A new consensus paper, published by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), the International Osteoporosis Foundation (IOF), and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), provides an updated evaluation of reference bone turnover markers (BTMs) and newer markers in the diagnosis and management
Maintaining a healthy diet rich in plant-based foods, with low to moderate intake of healthy animal-based foods and lower intake of ultra-processed foods, was linked to a higher likelihood of healthy aging—defined as reaching age 70 free of major chronic diseases and with cognitive, physical, and mental health maintained, according to a new study by
Researchers showed that older patients with heart failure who exercised regularly before hospitalization had better physical function and lower mortality Exercise is widely recognized as beneficial for patients with heart failure, with current guidelines relying on introducing exercise after heart failure diagnosis. This leaves a noticeable lack of research on the impact of habitual physical
Alzheimer disease (AD), the most common cause of cognitive impairment, is characterized by β-amyloid (Aβ) plaques and tau neurofibrillary tangles, which lead to neuroinflammation, neurodegeneration, and cognitive decline. Among various interventions, physical activity (PA) is widely recommended. Numerous studies suggest that PA not only slows cognitive decline but also improves specific cognitive functions. Potential mechanisms underlying the protective
The use of semaglutide (Ozempic) was tied to a risk of nonarteritic anterior ischemic optic neuropathy (NAION) in adults with type 2 diabetes, according to a retrospective study. In this review of 37.1 million patients, the incidence rate of NAION among semaglutide users was 14.5 and 8.7 per 100,000 person-years using the sensitive and specific
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings. However, over the past few years, these medications have become popular due to their weight loss and weight management benefits. Outside of nutrition, physical activity and surgery, Dr. Saundra Nguyen, assistant professor of internal medicine at Baylor College of Medicine, explaining
A simple scoring system could revolutionise how doctors prevent heart attacks and strokes by identifying patients most likely to benefit from preventive medications, according to a new study. The breakthrough test, called the TRIPLE Score, (Thrombotic Reactivity Indicator using Platelet GPVI, CD36 [cluster of differentiation 36] Expression, and age) measures specific proteins on blood platelets
The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people with certain kinds of chronic back pain. The systematic review is published on February 12, 2025, online in Neurology®. It updates
GLP-1 medications tied to decreased risk of dementia, addiction; increased risk of kidney, pancreas and gastrointestinal problems Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease
